75
0 Annual Meeting of Shareholders Annual Meeting of Shareholders April 23, 2009 April 23, 2009 Atlanta, Georgia Atlanta, Georgia
0
Annual Meeting of ShareholdersAnnual Meeting of Shareholders
April 23, 2009April 23, 2009Atlanta, GeorgiaAtlanta, Georgia
1
Announcements and Forward-Looking Statement
Announcements and Forward-Looking Statement
Matt LeporeMatt LeporeChief Counsel and Corporate SecretaryChief Counsel and Corporate Secretary
2
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
3
Announcements and Forward-Looking Statement
Announcements and Forward-Looking Statement
Matt LeporeMatt LeporeChief Counsel and Corporate SecretaryChief Counsel and Corporate Secretary
4
Chairman’s Welcome and ReportChairman’s Welcome and Report
Jeff KindlerJeff KindlerChairman and Chief Executive OfficerChairman and Chief Executive Officer
5
Overcome patent expirations, keeprevenues steady
Improve R&D productivity
Manage costs
Strengthen our culture
Overcome patent expirations, keepOvercome patent expirations, keeprevenues steadyrevenues steady
Improve R&D productivityImprove R&D productivity
Manage costsManage costs
Strengthen our cultureStrengthen our culture
Achieving Our Stated GoalsAchieving Our Stated Goals
6
Chairman’s ReportChairman’s Report
Jeff KindlerJeff KindlerChairman and Chief Executive OfficerChairman and Chief Executive Officer
7
Asking the Tough QuestionsAsking the Tough Questions
Jeff KindlerJeff KindlerChairman and Chief Executive OfficerChairman and Chief Executive Officer
8
How is Pfizer doing in this time of extreme economic turmoil?
How is Pfizer doing in this time of extreme economic turmoil?
9
Pfizer: Strong Financesand Operations
Pfizer: Strong Financesand Operations
Strong Financially
Strong balance sheet
Excellent liquidity, cash flow, credit ratings
Conservative investment practices
Solid Operational Performance
On track for 2009 goals
Strong FinanciallyStrong Financially
Strong balance sheetStrong balance sheet
Excellent liquidity, cash flow, credit ratingsExcellent liquidity, cash flow, credit ratings
Conservative investment practicesConservative investment practices
Solid Operational PerformanceSolid Operational Performance
On track for 2009 goalsOn track for 2009 goals
10
Chairman’s ReportChairman’s Report
Jeff KindlerJeff KindlerChairman and Chief Executive OfficerChairman and Chief Executive Officer
11
Why did Pfizer cut its dividend?Why did Pfizer cut its dividend?
12
Chairman’s ReportChairman’s Report
Jeff KindlerJeff KindlerChairman and Chief Executive OfficerChairman and Chief Executive Officer
13
Why is Pfizer buying Wyeth?Why is Pfizer buying Wyeth?
14
Pfizer-Wyeth: A Transformational Move
Pfizer-Wyeth: A Transformational Move
Extends Global Healthcare Global Healthcare LeadershipLeadership
Strengthens Platforms for Strengthens Platforms for Improved, Consistent and Improved, Consistent and Stable Earnings GrowthStable Earnings Growth
Drives Improved Drives Improved Performance Through Performance Through
Unique, Flexible Business Unique, Flexible Business ModelModel
Enhances Ability to Meet Enhances Ability to Meet Unmet NeedsUnmet Needs
of Patients, Physicians and of Patients, Physicians and Other CustomersOther Customers
Creating the World’s Premier Biopharmaceutical Company
15
Extends Global Healthcare Global Healthcare LeadershipLeadership
Strengthens Platforms for Strengthens Platforms for Improved, Consistent and Improved, Consistent and Stable Earnings GrowthStable Earnings Growth
Drives Improved Drives Improved Performance Through Performance Through
Unique, Flexible Business Unique, Flexible Business ModelModel
Pfizer-Wyeth: A Transformational Move
Pfizer-Wyeth: A Transformational Move
Enhances Ability to Meet Enhances Ability to Meet Unmet NeedsUnmet Needs
of Patients, Physicians and of Patients, Physicians and Other CustomersOther Customers
Creating the World’s Premier Biopharmaceutical Company
In developed and developing marketsPrimary and Specialty CareVaccines, Biologics and Small MoleculesAnimal Health, Consumer Health, Nutritionals
16
Extends Global Healthcare Global Healthcare LeadershipLeadership
Strengthens Platforms for Strengthens Platforms for Improved, Consistent and Improved, Consistent and Stable Earnings GrowthStable Earnings Growth
Drives Improved Drives Improved Performance Through Performance Through
Unique, Flexible Business Unique, Flexible Business ModelModel
Pfizer-Wyeth: A Transformational Move
Pfizer-Wyeth: A Transformational Move
Enhances Ability to Meet Enhances Ability to Meet Unmet NeedsUnmet Needs
of Patients, Physicians and of Patients, Physicians and Other CustomersOther Customers
Creating the World’s Premier Biopharmaceutical Company
Focused, agile business unitsFocused, agile business unitsStrong resources, scale of global Strong resources, scale of global enterpriseenterpriseRapid and effective integration of Rapid and effective integration of WyethWyeth
17
Extends Global Healthcare Global Healthcare LeadershipLeadership
Strengthens Platforms for Strengthens Platforms for Improved, Consistent and Improved, Consistent and Stable Earnings GrowthStable Earnings Growth
Drives Improved Drives Improved Performance Through Performance Through
Unique, Flexible Business Unique, Flexible Business ModelModel
Enhances Ability to Meet Enhances Ability to Meet Unmet NeedsUnmet Needs
of Patients, Physicians and of Patients, Physicians and Other CustomersOther Customers
Definitively addresses revenue loss Definitively addresses revenue loss from Lipitor loss of exclusivityfrom Lipitor loss of exclusivityBroad, diversified portfolio of growth Broad, diversified portfolio of growth driversdriversNew therapies: largest selling New therapies: largest selling vaccine, best selling biologic vaccine, best selling biologic medicinemedicine
Pfizer-Wyeth: A Transformational Move
Pfizer-Wyeth: A Transformational Move
Creating the World’s Premier Biopharmaceutical Company
18
Extends Global Healthcare Global Healthcare LeadershipLeadership
Strengthens Platforms for Strengthens Platforms for Improved, Consistent and Improved, Consistent and Stable Earnings GrowthStable Earnings Growth
Drives Improved Drives Improved Performance Through Performance Through
Unique, Flexible Business Unique, Flexible Business ModelModel
Enhances Ability to Meet Enhances Ability to Meet Unmet NeedsUnmet Needs
of Patients, Physicians and of Patients, Physicians and Other CustomersOther Customers
Augments inAugments in--line and pipeline portfolio in line and pipeline portfolio in critical disease areascritical disease areasEnhance our scientific and manufacturing Enhance our scientific and manufacturing capabilitiescapabilitiesOpens doors of opportunity for talented Opens doors of opportunity for talented peoplepeopleBroad diversity of product lines; stable of Broad diversity of product lines; stable of fast growing medicinesfast growing medicines
Pfizer-Wyeth: A Transformational Move
Pfizer-Wyeth: A Transformational Move
Creating the World’s Premier Biopharmaceutical Company
19
Pfizer-Wyeth: A Transformational Move
Pfizer-Wyeth: A Transformational Move
Extends Global Healthcare Global Healthcare LeadershipLeadership
Strengthens Platforms for Strengthens Platforms for Improved, Consistent and Improved, Consistent and Stable Earnings GrowthStable Earnings Growth
Drives Improved Drives Improved Performance Through Performance Through
Unique, Flexible Business Unique, Flexible Business ModelModel
Enhances Ability to Meet Enhances Ability to Meet Unmet NeedsUnmet Needs
of Patients, Physicians and of Patients, Physicians and Other CustomersOther Customers
Creating the World’s Premier Biopharmaceutical Company
20
What has happened to Pfizer’s share price since the Wyeth
announcement?
What has happened to Pfizer’s share price since the Wyeth
announcement?
21
Chairman’s ReportChairman’s Report
Jeff KindlerJeff KindlerChairman and Chief Executive OfficerChairman and Chief Executive Officer
22
What’s happeningwith the pipeline?What’s happeningwith the pipeline?
23
Driving R&D Productivity Driving R&D Productivity
Two new high-potential products in Phase 3
–JAK-3 inhibitor: a new approach to Rheumatoid Arthritis
–Tanezumab: a new approach toknee pain
Two new highTwo new high--potential products in potential products in Phase 3Phase 3
––JAKJAK--3 inhibitor: a new approach to 3 inhibitor: a new approach to Rheumatoid ArthritisRheumatoid Arthritis
––TanezumabTanezumab: a new approach to: a new approach toknee painknee pain
24
A Broad, Diverse, High-Value PipelineA Broad, Diverse, High-Value Pipeline
21 advancedsince September 2008
2121 advancedadvancedsince September 2008since September 2008
100 Programs in Pipeline100 Programs in Pipeline100 Programs in Pipeline
12 of these in high-prioritydisease areas, including diabetes,
cancer, Alzheimer’s disease and others
1212 of these in highof these in high--priorityprioritydisease areas, including diabetes,disease areas, including diabetes,
cancer, Alzheimercancer, Alzheimer’’s disease and otherss disease and others
Phase 2Phase 2 Phase 3Phase 3 In Reg.In Reg.
4040 3333 2525 22Phase 1Phase 1 TotalTotal
100100
Discovery Discovery ProjectsProjects
25
Poised to Make Progress on All FrontsPoised to Make Progress on All Fronts
Business UnitsBusiness Units
DevelopmentDevelopment Sales & Sales & MarketingMarketingMedicalMedical
PharmaTherapeuticsPharmaTherapeuticsResearch Group Research Group
BioTherapeuticsBioTherapeuticsResearch Group Research Group
26
R&D Is Focused on Critical DiseasesR&D Is Focused on Critical Diseases
Expands High Priority Disease Areasand Enhances Biologics CapabilitiesExpands High Priority Disease Areasand Enhances Biologics Capabilities
VaccinesVaccines Infectious Infectious DiseasesDiseases
BiotherapeuticsBiotherapeutics
AlzheimerAlzheimer’’ss ArthritisArthritis CancerCancer DiabetesDiabetes
27
28
Chairman’s ReportChairman’s Report
Jeff KindlerJeff KindlerChairman and Chief Executive OfficerChairman and Chief Executive Officer
29
What was your compensationin 2008, and why was it set at
that level?
What was your compensationin 2008, and why was it set at
that level?
30
Chairman’s ReportChairman’s Report
Jeff KindlerJeff KindlerChairman and Chief Executive OfficerChairman and Chief Executive Officer
31
Your Interests Are Our InterestsYour Interests Are Our Interests
32
Why should you invest in Pfizer?Why should you invest in Pfizer?
33
Pfizer: Within Our ReachPfizer: Within Our Reach
Market leadership in key regions…and in medicines and animal health
Leadership in primary and specialty care
A dynamic oncology business
Highly innovative vaccines business
A leading biotherapeutics business
A broadly based Established Products business
Solid positions in diverse businesses
A strong late stage pipeline and leading edgescientific collaborations
Market leadership Market leadership in key regionsin key regions……and in medicines and animal healthand in medicines and animal health
LeadershipLeadership in primary and specialty carein primary and specialty care
A A dynamicdynamic oncology businessoncology business
Highly innovativeHighly innovative vaccines businessvaccines business
A leading A leading biotherapeuticsbiotherapeutics businessbusiness
A broadly based A broadly based Established ProductsEstablished Products businessbusiness
Solid positions in Solid positions in diverse businessesdiverse businesses
A strong late stage pipeline and A strong late stage pipeline and leading edgeleading edgescientific collaborationsscientific collaborations
35
Chairman’s ReportChairman’s Report
Jeff KindlerJeff KindlerChairman and Chief Executive OfficerChairman and Chief Executive Officer
36
Call to Order For Business MeetingCall to Order For Business Meeting
37
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
38
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
39
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
40
A Quorum is PresentA Quorum is Present
41
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
42
To Ensure Fair Play for All Shareholders
To Ensure Fair Play for All Shareholders
Please hold questions or comments about an Item until after it has been introduced
Please focus only on the Item being discussed
Please wait for a microphone
When recognized, please state your name and shareholder status
Please respect time limits
Please hold questions or comments about an Please hold questions or comments about an Item until Item until afterafter it has been introducedit has been introduced
Please focus only on the Item being discussedPlease focus only on the Item being discussed
Please wait for a microphonePlease wait for a microphone
When recognized, please state your name and When recognized, please state your name and shareholder statusshareholder status
Please respect time limitsPlease respect time limits
43
Voting – Or Changing Your VoteVoting – Or Changing Your Vote
44
The Polls Are OpenThe Polls Are Open
45
Item 1:Item 1:Election of Election of DirectorsDirectors
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
46
Dr. Dennis A. AusielloDr. Dennis A. Ausiello
Chief of Medicine, Chief of Medicine, Massachusetts General HospitalMassachusetts General Hospital
47
Dr. Michael S. BrownDr. Michael S. Brown
Distinguished Chair, Biomedical Sciences, Distinguished Chair, Biomedical Sciences, University of Texas / Southwestern University of Texas / Southwestern
Medical Center Medical Center
48
M. Anthony BurnsM. Anthony Burns
Chairman Emeritus, Chairman Emeritus, Ryder System, Inc Ryder System, Inc
49
Robert N. BurtRobert N. Burt
Retired Chairman and CEO, Retired Chairman and CEO, FMC Corporation FMC Corporation
50
W. Don CornwellW. Don Cornwell
Chairman and CEO, Chairman and CEO, Granite Broadcasting Corporation Granite Broadcasting Corporation
51
William H. Gray, IIIWilliam H. Gray, III
Chairman, Chairman, AmaniAmani Group Group
52
Constance J. HornerConstance J. Horner
Former Assistant to the President of the United Former Assistant to the President of the United States, and Director of Presidential Personnel States, and Director of Presidential Personnel
53
James M. KiltsJames M. Kilts
Founding Partner of Founding Partner of CenterviewCenterview Partners Partners
54
George A. LorchGeorge A. Lorch
Chairman Emeritus, Chairman Emeritus, Armstrong Holdings, Inc Armstrong Holdings, Inc
55
Dr. Dana G. MeadDr. Dana G. Mead
Chairman, Chairman, MIT Corporation MIT Corporation
56
Suzanne Nora JohnsonSuzanne Nora Johnson
Former Vice Chairman, Former Vice Chairman, The Goldman Sachs Group, IncorporatedThe Goldman Sachs Group, Incorporated
57
Stephen W. SangerStephen W. Sanger
Former Chairman, Former Chairman, General MillsGeneral Mills
58
William C. Steere, Jr., William C. Steere, Jr.,
Chairman of the Board, Emeritus, Chairman of the Board, Emeritus, Pfizer Inc Pfizer Inc
59
Item 1:Item 1:Election of Election of DirectorsDirectors
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
60
William R. HowellWilliam R. Howell
Chairman Emeritus, Chairman Emeritus, J.C. Penney Company J.C. Penney Company
61
Item 1:Item 1:Election of Election of DirectorsDirectors
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
62
Item 2:Item 2:Ratifying Ratifying SelectionSelectionof KPMGof KPMG
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
63
Item 3:Item 3:ShareholderShareholder
ProposalProposalon 2004 Pfizeron 2004 PfizerStock PlanStock Plan
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
64
Item 4:Item 4:ShareholderShareholder
ProposalProposalOn StockOn StockOptionsOptions
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
65
Item 5:Item 5:ShareholderShareholder
ProposalProposalOn AdvisoryOn Advisory
Vote OnVote OnCompensationCompensation
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
66
Item 6:Item 6:Shareholder Shareholder Proposal On Proposal On CumulativeCumulative
VotingVoting
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
67
Item 7:Item 7:Shareholder Shareholder Proposal OnProposal On
SpecialSpecialShareholder Shareholder
MeetingsMeetings
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
68
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
69
The Polls Are ClosedThe Polls Are Closed
70
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
71
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
72
Order of BusinessOrder of Business
I. Chairman’s Welcome and Report
II. Call to Order for Business Meeting
III. Declaration of a Quorum
IV. Voting Items
V. Final Voting and Closing of Polls
VI. Preliminary Results of Voting
VII. Questions and Answers
VIII. Adjournment
I.I. ChairmanChairman’’s Welcome and Reports Welcome and Report
II.II. Call to Order for Business MeetingCall to Order for Business Meeting
III.III. Declaration of a QuorumDeclaration of a Quorum
IV.IV. Voting ItemsVoting Items
V.V. Final Voting and Closing of PollsFinal Voting and Closing of Polls
VI.VI. Preliminary Results of VotingPreliminary Results of Voting
VII.VII. Questions and AnswersQuestions and Answers
VIII.VIII. AdjournmentAdjournment
73
Thank You!Thank You!
74
Annual Meeting of ShareholdersAnnual Meeting of Shareholders
April 23, 2009April 23, 2009Atlanta, GeorgiaAtlanta, Georgia
